Free Trial

Analysts Set Xometry, Inc. (NASDAQ:XMTR) Price Target at $33.33

Xometry logo with Industrial Products background

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and six have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $33.33.

XMTR has been the subject of several recent analyst reports. Cantor Fitzgerald reissued an "underweight" rating and set a $12.00 price objective on shares of Xometry in a report on Wednesday, November 6th. Craig Hallum increased their price target on shares of Xometry from $20.00 to $30.00 and gave the stock a "buy" rating in a report on Wednesday, November 6th. JMP Securities reiterated a "market outperform" rating and issued a $42.00 target price on shares of Xometry in a research report on Monday, December 16th. Royal Bank of Canada raised their price target on Xometry from $27.00 to $40.00 and gave the company a "sector perform" rating in a research report on Friday, January 3rd. Finally, JPMorgan Chase & Co. upgraded Xometry from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $25.00 to $45.00 in a report on Wednesday, December 18th.

Get Our Latest Analysis on XMTR

Xometry Price Performance

Shares of XMTR traded up $0.86 during mid-day trading on Wednesday, reaching $34.15. 682,020 shares of the stock traded hands, compared to its average volume of 767,024. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. Xometry has a 1 year low of $11.08 and a 1 year high of $45.33. The company has a market cap of $1.69 billion, a price-to-earnings ratio of -32.52 and a beta of 0.70. The firm has a fifty day moving average price of $35.16 and a 200 day moving average price of $23.58.

Insider Transactions at Xometry

In related news, Director Emily Rollins sold 3,729 shares of Xometry stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $29.49, for a total value of $109,968.21. Following the transaction, the director now directly owns 12,457 shares of the company's stock, valued at $367,356.93. The trade was a 23.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Peter Goguen sold 12,000 shares of the stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $29.55, for a total transaction of $354,600.00. Following the sale, the chief operating officer now directly owns 180,419 shares of the company's stock, valued at $5,331,381.45. The trade was a 6.24 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 44,605 shares of company stock worth $1,430,140. Company insiders own 16.79% of the company's stock.

Institutional Trading of Xometry

A number of institutional investors have recently modified their holdings of the company. Weiss Asset Management LP bought a new position in Xometry during the 3rd quarter valued at approximately $1,586,000. Barclays PLC increased its stake in shares of Xometry by 360.9% during the third quarter. Barclays PLC now owns 68,951 shares of the company's stock valued at $1,266,000 after buying an additional 53,991 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Xometry during the third quarter valued at approximately $355,000. Versor Investments LP bought a new position in shares of Xometry during the third quarter valued at approximately $411,000. Finally, Allspring Global Investments Holdings LLC lifted its stake in Xometry by 191.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 216,700 shares of the company's stock worth $3,981,000 after acquiring an additional 142,262 shares during the period. 97.31% of the stock is currently owned by hedge funds and other institutional investors.

Xometry Company Profile

(Get Free Report

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Read More

Analyst Recommendations for Xometry (NASDAQ:XMTR)

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines